A recent resurgence of historical warnings from Tylenol has sparked renewed debate over medication use during pregnancy, coinciding with comments by former President Donald Trump linking the drug to autism.
In 2017, Tylenol issued advisories cautioning pregnant women against taking the medication without medical consultation, acknowledging that it had not been thoroughly tested for safety during pregnancy. This message resurfaced as Trump highlighted claims from Robert F. Kennedy Jr.’s investigation suggesting a potential connection between prenatal Tylenol use and autism in children. The former president reportedly urged expectant mothers to avoid the drug.
Social media discussions have since circulated examples of individuals disregarding these warnings, including a pregnant physician who openly took Tylenol despite publicized concerns. Critics have questioned such actions, framing them as disregard for established health guidance.
The White House’s response to the resurfaced advisories underscored repeated caution from pharmaceutical companies regarding medication use during pregnancy. No official statements from medical authorities were cited in the original text.
